Login
From:
ALS News Today
(Uncensored)
subscribe
PrimeC can significantly slow ALS progression: PARADIGM trial
https://alsnewstoday.com/news/primec-showed-significant-clinical-efficacy-paradigm-trial-new-data/
links
backlinks
Tagged with:
primec
als progression
neurosense therapeutics
An analysis in 62 ALS patients who followed the Phase 2b study's rules (protocol) found a 37.4% ALSFRS-R difference with PrimeC vs. placebo.
Roast topics
Find topics
Find it!
